Credo Therapies
·
United Kingdom·Active·4yr hold
United Kingdom·Active·4yr holdEntry
2022
Hold
4yr
Status
Active
Who owns Credo Therapies?
Credo Therapies is a British company, currently owned by Oxford Science Enterprises since 2022.
Hand-verified · updated 2026-09-29
Open JSON · CC-BY
More from Oxford Science Enterprises Balance Sheet
Other portfolio companies in the same fund.
United StatesQuestions
Who owns Credo Therapies?
Credo Therapies is currently owned by Oxford Science Enterprises, through Oxford Science Enterprises Balance Sheet, since 2022.
When did Oxford Science Enterprises acquire Credo Therapies?
Oxford Science Enterprises acquired Credo Therapies in 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue